Clinical development of endothelin receptor antagonists
- 31 July 1997
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 18 (4) , 408-412
- https://doi.org/10.1016/s0165-6147(97)90670-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- ABSENCE OF ETB-MEDIATED CONTRACTION IN PIEBALD-LETHAL MICELife Sciences, 1997
- Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouseBritish Journal of Pharmacology, 1997
- Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in micePublished by Elsevier ,1994
- Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neuronsCell, 1994
- Novel receptor antagonists welcome a new era in endothelin biologyTrends in Pharmacological Sciences, 1994
- Elevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1Nature, 1994
- Clearance of Circulating Endothelin-1 by ETB Receptors in RatsBiochemical and Biophysical Research Communications, 1994